Epcoritamab
Drug timelines are a Plus or Pro feature.
33 regulatory and trial events tracked for Epcoritamab, covering 2024-09-26 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma [Phase 2]